QC
CVAC

QCM Cayman’s CureVac CVAC Stock Holding History

QCM Cayman’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,744
Closed -$202K – 124
2021
Q2 		$202K Buy
+2,744
New +$274K 0.52% 91

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

QCM Cayman's CVAC Position: Q3 2021 in Review

QCM Cayman sold out of CureVac (CVAC) in Q3 2021, closing a stake of 2,744 shares — an estimated $202K sold.

QCM Cayman first reported a position in CVAC in Q2 2021 and held it in 1 quarter. The position peaked at $202K in Q2 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

  • QCM Cayman reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
  • QCM Cayman sold 2,744 CureVac shares in Q3 2021, an estimated $202K.
  • QCM Cayman first reported a position in CureVac in Q2 2021 and held it in 1 quarter.
  • QCM Cayman's CureVac position peaked at $202K in Q2 2021.
  • 111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on QCM Cayman's 13F filing for Q3 2021, filed 1 Nov 2021.